- Report
- February 2026
- 129 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 453 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- January 2026
- 196 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 187 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 181 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- August 2025
- 196 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- October 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- November 2025
- 182 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 180 Pages
Global
From €3936EUR$4,500USD£3,396GBP
- Report
- January 2026
- 181 Pages
Global
From €3936EUR$4,500USD£3,396GBP
- Report
- June 2025
- 185 Pages
Global
From €3936EUR$4,500USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- July 2025
- 175 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- February 2025
- 200 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- January 2026
- 181 Pages
Global
From €3936EUR$4,500USD£3,396GBP
- Report
- February 2026
- 497 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 405 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 541 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 213 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- August 2025
- 192 Pages
Global
From €3445EUR$3,939USD£2,973GBP

Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more